Article Details

ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with ...

Retrieved on: 2021-09-27 05:03:45

Tags for this article:

Click the tags to see associated articles and topics

ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with .... View article details on hiswai:

Excerpt

Rockville, MD, USA, and Pratteln, Switzerland, September 27, 2021 – ReveraGen Biopharma and Santhera Pharmaceuticals (SIX: SANN) announce that ReveraGen has ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up